Accretion Pharmaceuticals share price is ₹133.65 as of 3 Jun, 2026. The stock Accretion Pharmaceuticals intraday movement has stayed between ₹127.00 and ₹133.85, while on a 52-week basis,Accretion Pharmaceuticals price 52 week high is ₹133.85 & its 52 week low is ₹53.80.
In terms of trading activity, Accretion Pharmaceuticals has recorded a volume of 63600 shares, The Accretion Pharmaceuticals has a market cap of ₹11116000 CR. The stock’s Average Traded Price (ATP) stands at ₹131.73, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1200 @ ₹133.65.
Accretion Pharmaceuticals operates within a circuit range of ₹121.15 – ₹133.85, with a Value of ₹83.78 L. The Delivery Percentage for the day is 95.24%. Additionally, Accretion Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1200.
The Buying Price of Accretion Pharmaceuticals share is 133.65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Accretion Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Accretion Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Accretion Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Accretion Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Accretion Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.53 & 2.99 with sector averages, along with growth rates and financial metrics.
The Market Cap of Accretion Pharmaceuticals is 148.57 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Accretion Pharmaceuticals share price is 133.85 & 53.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Accretion Pharmaceuticals belongs to the Healthcare sector.